相关实验视频
Updated: Jun 29, 2025

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
在出生时修改血小板:没有出血的抗血栓治疗
Conor Feely1, Nitika Kaushal1, Pier Paolo D'Avino2
1Centre for Clinical Pharmacology, Institute of Health Informatics, University College London, London, United Kingdom.
减少巨核细胞流症为预防心血管疾病中的动脉血栓形成提供了一种新的策略. 这种方法旨在产生不那么活跃的血小板,从而减少与当前抗血小板疗法相关的出血风险.
科学领域:
- 心血管医学 心血管医学
- 血液学 血液学 血液学
- 血栓形成研究研究
背景情况:
- 心血管疾病仍然是全球死亡的主要原因.
- 目前用于动脉血栓的抗血小板疗法具有显著的出血风险.
- 血小板活动是血栓形成的关键因素,在血小板形成之前确定.
研究的目的:
- 探索一种新的治疗策略,通过向大核细胞性减少来预防和治疗血栓形成.
- 调查调节巨核细胞内分泌和血小板血栓潜力的机制.
- 为了确定产生血静能力,非血栓性血小板的途径.
主要方法:
- 检查受体介导的事件,从而增加巨核细胞 ploidy.
- 调查巨核细胞内分子标的研究.
- 通过调节血小板血栓潜力来分析维持血静的调节途径.
主要成果:
- 增加的巨核细胞流动与更大,更活跃的血小板和高血栓形成风险相关.
- 确定了巨核细胞流调节和血小板功能中的潜在治疗点.
- 提出了新的方法来调节血小板血栓潜力.
结论:
- 减少巨核细胞流症为预防血栓形成提供了一个有前途的治疗途径.
- 准巨核细胞内和血小板调节通路可能会产生更安全的抗血栓治疗方法.
- 这一策略旨在平衡血静与降低血栓形成风险.
更多相关视频
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Clot Retraction and Fibrinolysis